SECOND MODIFICATION AND EXCHANGE AGREEMENTModification and Exchange Agreement • March 13th, 2015 • Omni Bio Pharmaceutical, Inc. • Biological products, (no disgnostic substances) • Colorado
This SECOND MODIFICATION AND EXCHANGE AGREEMENT (the “Agreement”), is dated as of March 12, 2015 (the “Effective Date”), between Omni Bio Pharmaceutical, Inc., 181 W. Boardwalk Drive, Suite 202, Fort Collins, CO (the “Company”) and Bohemian Investments, LLC, 262 East Mountain Ave., Fort Collins, CO (the “Noteholder”).
MODIFICATION AND EXCHANGE AGREEMENTModification and Exchange Agreement • April 25th, 2023 • Allarity Therapeutics, Inc. • Pharmaceutical preparations • New York
THIS MODIFICATION AND EXCHANGE AGREEMENT (the “Agreement” or the “Exchange Agreement”) is as of April 20, 2023, by and between Allarity Therapeutics, Inc., a Delaware corporation (the “Company”), and 3i, LP, a Delaware limited partnership (“Preferred Holder”).
MODIFICATION AND EXCHANGE AGREEMENTModification and Exchange Agreement • February 2nd, 2015 • Omni Bio Pharmaceutical, Inc. • Biological products, (no disgnostic substances) • Colorado
This MODIFICATION AND EXCHANGE AGREEMENT (the “Agreement”), is dated as of January 23, 2015 (the “Effective Date”), between Omni Bio Pharmaceutical, Inc., 181 W. Boardwalk Drive, Suite 202, Fort Collins, CO (the “Company”) and Bohemian Investments, LLC, 262 East Mountain Ave., Fort Collins, CO (the “Noteholder”).
AMENDMENT TO MODIFICATION AND EXCHANGE AGREEMENTModification and Exchange Agreement • June 1st, 2023 • Allarity Therapeutics, Inc. • Pharmaceutical preparations
THIS AMENDMENT TO MODIFICATION AND EXCHANGE AGREEMENT (the “Amendment”) dated as of May 26, 2023, is effective as of April 20, 2023, by and between Allarity Therapeutics, Inc., a Delaware corporation (the “Company”), and 3i, LP, a Delaware limited partnership (“Preferred Holder”). The Company and the Preferred Holder, each referred to herein as a “Party” and collectively, as the “Parties.”
